King International Investment (HKSE:00928) EBIT per Share : HK$-0.02 (TTM As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is King International Investment EBIT per Share?

King International Investment's EBIT per Share for the six months ended in Sep. 2023 was HK$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 was HK$-0.02.

During the past 3 years, the average EBIT per Share Growth Rate was -5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for King International Investment's EBIT per Share or its related term are showing as below:

HKSE:00928' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -73.1 Med: 11.9 Max: 49.6
Current: -5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of King International Investment was 49.60% per year. The lowest was -73.10% per year. And the median was 11.90% per year.

HKSE:00928's 3-Year EBIT Growth Rate is ranked worse than
56.65% of 173 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.7 vs HKSE:00928: -5.00

King International Investment's EBIT for the six months ended in Sep. 2023 was HK$2.8 Mil.

King International Investment EBIT per Share Historical Data

The historical data trend for King International Investment's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment EBIT per Share Chart

King International Investment Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT per Share

Get a 7-Day Free Trial

-0.11

-0.02

-0.03

-0.02

King International Investment Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBIT per Share	Get a 7-Day Free Trial															-	-0.03	-	-0.02	-

King International Investment EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

King International Investment's EBIT per Share for the fiscal year that ended in Mar. 2023 is calculated as

	EBIT per Share		(A: Mar. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-30.482	/	1475.135
=	-0.02

King International Investment's EBIT per Share for the quarter that ended in Sep. 2023 is calculated as

	EBIT per Share		(Q: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	2.782	/	1542.025
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.02

King International Investment (HKSE:00928) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

King International Investment EBIT per Share Related Terms

Thank you for viewing the detailed overview of King International Investment's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

King International Investment (HKSE:00928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG

Website

https://www.lifehealthcare.com

King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines